Abstract
145 - Evaluation of the Efficacy and Safety of Darbepoetin Alfa in Reducing the Transfusion Requirements in Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation for Hematological Malignancies
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
